Cook Jennifer E.
SEC insider (Form 3/4/5 filer). CIK 0001754371. Director at Jazz Pharmaceuticals plc (JAZZ) and 2 other issuers. 22 reported Form 4/5 transactions since Sep 2024; latest on Aug 31, 2026. Located in DUBLIN 4.
Companies Cook Jennifer E. has filed insider reports for
- Jazz Pharmaceuticals plc (JAZZ): Director
- BridgeBio Pharma, Inc. (BBIO): Director
- Denali Therapeutics Inc. (DNLI): Director
Cook Jennifer E.
CIK: 0001754371
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (22 total)
- Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect14 shares at avg. $244.06$3K - Aug 31, 2026JAZZ
Jazz Pharmaceuticals plc
Tax PaymentDirect1.7K shares at avg. $241.39$408K - Aug 5, 2026JAZZ
Jazz Pharmaceuticals plc
AwardDirect1.6K shares- - Jul 9, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect36.2K shares at avg. $84.00$3.0M - Jul 9, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect19K shares at avg. $8.45$161K - Jul 9, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect17.2K shares at avg. $16.75$288K - Jul 9, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect112.4K shares at avg. $29.00$3.3M - Jul 9, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect112.4K shares at avg. $90.00$10.1M - Jun 24, 2026BBIO
BridgeBio Pharma, Inc.
SaleDirect37.2K shares at avg. $70.00$2.6M - Jun 24, 2026BBIO
BridgeBio Pharma, Inc.
ExerciseDirect20K shares at avg. $8.45$169K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Aug 31, 2026 |  JAZZ Jazz Pharmaceuticals plc | Tax Payment | 14 | $244.06 | $3,417 | Direct |
| Aug 31, 2026 | JAZZ Jazz Pharmaceuticals plc | Tax Payment | 1,692 | $241.39 | $408,432 | Direct |
| Aug 5, 2026 | JAZZ Jazz Pharmaceuticals plc | Award | 1,605 | - | $0 | Direct |
| Jul 9, 2026 |  BBIO BridgeBio Pharma, Inc. | Sale | 36,167 | $84.00 | $3,038,028 | Direct |
| Jul 9, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 19,000 | $8.45 | $160,550 | Direct |
| Jul 9, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 17,167 | $16.75 | $287,547 | Direct |
| Jul 9, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 112,422 | $29.00 | $3,260,238 | Direct |
| Jul 9, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 112,422 | $90.00 | $10,117,980 | Direct |
| Jun 24, 2026 | BBIO BridgeBio Pharma, Inc. | Sale | 37,167 | $70.00 | $2,601,690 | Direct |
| Jun 24, 2026 | BBIO BridgeBio Pharma, Inc. | Exercise | 20,000 | $8.45 | $169,000 | Direct |
1-10 of 22 transactions